Repeated thoracic discharges from a stun device

Journal of Trauma - Injury, Infection and Critical Care

Volumn 62, Issue 5, 2007, Pages 1134-1142

  Valentino, Daniel J ^a,b   Walter, Robert J ^a,b   Nagy, Kimberly ^a,b   Dennis, Andrew J ^a,b   Winners, Jerry ^a   Bokhari, Faran ^a,b   Wiley, Dorion ^a,b   Joseph, Kimberly T ^a,b   Roberts, Roxanne ^a,b  

^a Department of Ambulatory and Community Health   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arrhythmia; Blood pressure; Cardiac effects; Electrocardiogram; Electromuscular incapacitation; Heart; Ketamine; Lactate; Metabolic acidosis; MK63; Respiratory acidosis; Stun baton; Stun gun; Swine; Troponin I; Ventricular fibrillation; Xylazine

Indexed keywords

GLYCOPYRRONIUM BROMIDE; KETAMINE; LACTIC ACID; TROPONIN I; XYLAZINE;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CHEMISTRY; BLOOD GAS; BLOOD PH; CARBON DIOXIDE TENSION; CONTROLLED STUDY; DEVICE; ELECTROCARDIOGRAPHY; ELECTROSTIMULATION; EXPOSURE; HEART ARRHYTHMIA; HEART RATE; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; SWINE; WAVEFORM;

ACID-BASE EQUILIBRIUM; ANIMALS; BLOOD PRESSURE; ELECTRIC STIMULATION; EQUIPMENT DESIGN; HEART RATE; SWINE; SWINE, MINIATURE; WATER-ELECTROLYTE BALANCE;

EID: 34248384420     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3180479858     Document Type: Article

References (47)

1. Koumbourlis AC. Electrical injuries. Crit Care Med. 2002;30:S424-S430.
2. Fish RM. Electric injury, part I: Treatment priorities, subtle diagnostic factors, and burns. J Emerg Med. 1999;17:977-983.
3. Oltman CL, Clark CB, Kane NL, et al. Coronary vascular dysfunction associated with direct current shock injury. Basic Res Cardiol. 2003;98:406-415.
4. Lee RC. Injury by electrical forces: pathophysiology, manifestations, and therapy. Curr Probl Surg. 1997;34:677-764.
5. Kalkan T, Demir M, Ahmed AS, et al. A dynamic study of the thermal components in electrical injury mechanism for better understanding and management of electric trauma: An animal model. Burns. 2004;30:334-340.
6. Luce EA. Electrical burns. Clin Plast Surg. 2000;27:133-143.
7. Lee RC, Zhang D, Hannig J. Biophysical injury mechanisms in electrical shock trauma. Annu Rev Biomed Eng. 2000;2:477-509.
8. Danielson JR, Capelli-Schellpfeffer M, Lee RC. Upper extremity electrical injury. Hand Clin. 2000;16:225-234.
9. Battershill P, Naughton B, Laur D, et al. TASER technology review and interim recommendations. Available at www.cprc.org/docs/bcopcc_final.pdf. Accessed March 4, 2007.
10. McDaniel WC, Stratbucker RA, Nerheim M, Brewer JE. Cardiac safety of neuromuscular incapacitating defensive devices. Pacing Clin Electrophysiol. 2005;28 Suppl 1:S284-S287.
11. Bleetman A, Steyn R, Lee C. Introduction of the Taser into British policing. Implications for UK emergency departments: an overview of electronic weaponry. Emerg Med J. 2004;21:136-140.
12. Bleetman A, Steyn, R. The advanced TASER: A medical review. Available at www.taser.com/documents/tasersubmit.pdf. Accessed March 20, 2007.
13. Roy OZ, Podgorski AS. Tests on a shocking device-the stun gun. Med Biol Eng Comput. 1989;27:445-448.
14. Bozeman WP. Withdrawal of TASER electroshock devices: too much, too soon. Ann Emerg Med. 2005;46:300-301.
15. Ordog GJ, Wasserberger J, Schlater T, Balasubramanium S. Electronic gun (Taser) injuries. Ann Emerg Med. 1987;16:73-78.
16. O'Brien DJ. Electronic weaponry-a question of safety. Ann Emerg Med. 1991;20:583-587.
17. Koscove EM. The TASER weapon: a new emergency medicine problem. Ann Emerg Med. 1985;14:1205-1208.
18. Levine SD, Sloane C, Chan T, Vilke G, Dunford J. Cardiac monitoring of subjects exposed to the TASER. Acad Emerg Med 2005;12:71.
19. Lakkireddy D, Wallick D, Ryschon K, et al. Effects of cocaine intoxication on the threshold for stun gun induction of ventricular fibrillation. J Am Coll Cardiol. 2006;48:805-811.
20. Ho JD, Miner JR, Lakkireddy DR, Bultman LL, Heegaard WG. Cardiovascular and physiologic effects of conducted electrical weapon discharge in resting adults. Acad Emerg Med. 2006;13:589-595.
21. Jauchem JR, Sherry CJ, Fines DA, Cook MC. Acidosis, lactate, electrolytes, muscle enzymes, and other factors in the blood of Sus scrofa following repeated TASER exposures. Forensic Sci Int. 2005;161:20-30.
22. Webster JG, Will JA, Sun H, et al. Can TASERs directly cause ventricular fibrillation. IFBME Proc. 2006;14:3307-3310.
23. Nanthakumar K, Billingsley IM, Masse S, et al. Cardiac electrophysiological consequences of neuromuscular incapacitating device discharges. J Am Coll Cardiol. 2006;48:798-804.
24. Swindle MM. Surgery, Anesthesia, and Experimental Techniques in Swine. Ames: Iowa State University Press; 1998.
25. Bollen PJA, Hansen AK, Rasmussen HJ. Important biological features. In: Suckow MA, ed. The Laboratory Swine. Boca Raton: CRC Press; 2000:1-14.
26. Kost GJ, Kirk JD, Omand K. A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB mass and isoforms, and myoglobin) in the diagnosis of acute myocardial infarction. Arch Pathol Lab Med. 1998;122:245-251.
27. Apple FS, Murakami MM, Quist HH, et al. Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values. Am J Clin Pathol. 2003;120:114-120.
28. Apple FS, Christenson RH, Valdes R Jr, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem. 1999;45:199-205.
29. Ng SM, Krishnaswamy P, Morissey R, et al. Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol. 2001;88:611-617.
30. Ng SM, Krishnaswamy P, Morrisey R, et al. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J Cardiol. 2001;87:994-999.
31. Apple FS, Murakami M, Panteghini M, et al. International survey on the use of cardiac markers. Clin Chem. 2001;47:587-588.
32. Apple FS, Wu AH. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem. 2001;47:377-379.
33. Perry SV. The regulation of contractile activity in muscle. Biochem Soc Trans. 1979;7:593-617.
34. Sinclair Research. Clinical Chemistry Values of Sinclair Pigs. Columbia, MO: Sinclair Research, 1991.
35. Parsons AH, Wells RE. Serum biochemistry of healthy Yucatan miniature pigs. Lab Animal Sci. 1986;36:428-430.
36. Brechbuhler T, Kaeslin M, Wyler F. Reference values of various blood constituents in young minipigs. J Clin Chem Biochem. 1984;22:301-304.
37. Waagstein LM, Wennberg E, Waagstein F, Haljamae H. Hypertonic saline without or with dextran-70 in the treatment of experimental acute myocardial ischemia and reperfusion. Crit Care Med. 1999;27:605-616.
38. Rixen D, Raum M, Holzgraefe B, et al. Local lactate and histamine changes in small bowel circulation measured by microdialysis in pig hemorrhagic shock. Shock. 2002;18:355-359.
39. Hicks TA, McGlone JJ, Whisnant CS, et al. Behavioral, endocrine, immune, and performance measures for pigs exposed to acute stress. J Anim Sci. 1998;76:474-483.
40. Apple FS, Ler R, Chung AY, Berger MJ, Murakami MM. Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome. Clin Chem. 2006;52:322-325.
41. Schlosberg M, Levin J, Batliwalla S, Daniels J. Stun Gun Fallacy: How the Lack of Taser Regulation Endangers Lives. Available at http://aclunc.org/ issues/criminal_justice/police_practices/ asset_upload_file384_3131.pdf. Accessed March 20, 2007.
42. Amnesty International. United States of America Excessive and Lethal Force? Amnesty International's concerns about deaths and ill-treatment involving police use of TASERS. http://www.amnestyusa. org/countries/usa/Taser_report. pdf. Accessed March 4, 2007.
43. Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald's Heart Disease: A Text Book of Cardiovascular Medicine. Philadelphia: Saunders; 2005:1158-1161.
44. Feng YJ, Chen C, Fallon JT, et al. Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model. Am J Clin Pathol. 1998;110:70-77.
45. Kontos MC, Shah R, Fritz LM, et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol. 2004;43:958-965.
46. Townsend CM, Beauchamp DR, Evers MB, Mattox KL, Sabiston DC. Sabiston Textbook of Surgery. Philadelphia: Saunders; 2004:425-426.
47. Stratton SJ, Rogers C, Brickett K, Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med. 2001;19:187-191.